Your browser doesn't support javascript.
loading
Coronary artery calcification in Takayasu's arteritis: clinical characteristics and risk factors.
Yang, Shiyu; Zhang, Nan; Zhao, Wenjing; Du, Juan; Gao, Na; Shi, Xuemei; Zhang, Yaxin; Liu, Jiayi; Pan, Lili.
Afiliación
  • Yang S; Department of Rheumatology and Immunology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Zhang N; Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Zhao W; Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Du J; Department of Rheumatology and Immunology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Gao N; Department of Rheumatology and Immunology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Shi X; Department of Rheumatology and Immunology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Zhang Y; Department of Rheumatology and Immunology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
  • Liu J; Department of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. ljy76519@163.com.
  • Pan L; Department of Rheumatology and Immunology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. lilypansxmu@sina.com.
Clin Exp Rheumatol ; 42(4): 843-851, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38607693
ABSTRACT

OBJECTIVES:

Coronary artery calcification (CAC) is frequently observed in Takayasu's arteritis (TAK). Our objective is to calculate the prevalence and severity of CAC in TAK, while evaluating the influence of traditional cardiovascular risk factors, glucocorticoid exposure, and disease activity on CAC.

METHODS:

This retrospective study involved 155 TAK patients. We measured the Agatston score by coronary computed tomography angiography (CCTA) and categorised all patients into groups with or without CAC (41 vs. 114) to compare clinical characteristics and ancillary findings between the two groups.

RESULTS:

Among the TAK patients, a total of 41 TAK patients (26.45%) exhibited CAC. Age of onset, disease duration, history of hypertension, history of hyperlipidaemia, Numano V and glucocorticoid use emerged as the independent risk factors for developing CAC in TAK (OR [95% CI] 1.084[1.028-1.142], p=0.003; 1.005 [1.001-1.010], p=0.020; 4.792 [1.713-13.411], p=0.003; 4.199 [1.087-16.219], p=0.037; 3.287 [1.070-10.100], p=0.038; 3.558[1.269-9.977], p=0.016). Nonetheless, CAC was not associated with disease activity. Moreover, the extent of calcification score in TAK showed a positive correlation with the number of traditional cardiovascular risk factors.

CONCLUSIONS:

We recommend CCTA screening for Numano V classified TAK patients. Glucocorticoid usage significantly escalates the risk of CAC. Therefore, in cases of effectively controlled disease, the inclusion of immunosuppressants aimed at reducing glucocorticoid dosage is advisable.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Angiografía Coronaria / Arteritis de Takayasu / Calcificación Vascular / Angiografía por Tomografía Computarizada Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Rheumatol Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de la Arteria Coronaria / Angiografía Coronaria / Arteritis de Takayasu / Calcificación Vascular / Angiografía por Tomografía Computarizada Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Exp Rheumatol Año: 2024 Tipo del documento: Article País de afiliación: China